Picture of Guard Therapeutics International AB (publ) logo

GUARD Guard Therapeutics International AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-81.9-115-115-99.9-107
Non-Cash Items0.520.672.832.827.68
Other Non-Cash Items
Changes in Working Capital3.7912.1-3.812.33-9.83
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-77.6-102-116-94.8-109
Other Investing Cash Flow Items00000
Sale of Business
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities00000
Financing Cash Flow Items0.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities176113-0.77962.7107
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash98.612.4-117-29.6-4.36